Effect of Human Cytochrome P450 2D6 Polymorphism on Progesterone Hydroxylation

被引:1
|
作者
Niwa, Toshiro [1 ]
Sasaki, Shoko [1 ]
Yamamoto, Yuka [1 ]
Tanaka, Mayu [1 ]
机构
[1] Shujitsu Univ, Sch Pharm, Naka Ku, 1-6-1 Nishigawara, Okayama 7038516, Japan
关键词
DOPAMINE FORMATION; GENETIC-POLYMORPHISM; STEROID-HORMONES; P-TYRAMINE; OXIDATION; SUBSTRATE; ALLOPREGNANOLONE; NEUROSTEROIDS; METABOLISM; ENZYMES;
D O I
10.1007/s13318-022-00784-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and Objectives Herein, hydroxylation activities at the 6 beta-position and 21-position of progesterone mediated by human cytochrome P450 (CYP) 2D6 and its variants and the effects of psychotropic drugs on these hydroxylation activities were compared to clarify whether CYP2D6 polymorphisms and psychotropic drugs impact neurosteroid levels in the brain. Methods Progesterone was incubated with CYP2D6.1, CYP2D6.2 (Arg296Cys, Ser486Thr), CYP2D6.10 (Pro34Ser, Ser486Thr), and CYP2D6.39 (Ser486Thr) in the absence or presence of typical psychotropic drugs (fluvoxamine, fluoxetine, paroxetine, fluphenazine, and milnacipran) and endogenous steroids (testosterone and cortisol). Then, 6 beta- and 21-hydroxyprogesterone levels were determined by high-performance liquid chromatography. Results Although the Michaelis-Menten constants (K-m) for progesterone 6 beta- and 21-hydroxylation reactions mediated by the different CYP2D6 variants were similar, the maximal velocity (V-max) values of the reactions mediated by CYP2D6.1 and CYP2D6.2 were the highest, followed by those mediated by CYP2D6.39 and CYP2D6.10. Thus, the of progesterone 6 beta- and/or 21-hydroxylation reactions mediated by CYP2D6.1 and CYP2D6.2 showed the highest V-max/K-m values, followed by the reactions mediated by CYP2D6.39. All investigated compounds inhibited progesterone 21-hydroxylation mediated by CYP2D6 variants at high concentrations. Interestingly, at low concentrations, fluoxetine increased progesterone 21-hydroxylation mediated by CYP2D6.1, but not that mediated by CYP2D6.2 or CYP2D6.10. In addition, the K-m value for CYP2D6.2 was elevated in the presence of fluoxetine, whereas the value for CYP2D6.1 was unaltered; however, V-max values of both CYP2D6.1 and CYP2D6.2 were increased. Paroxetine competitively inhibited CYP2D6.1- and CYP2D6.2-mediated progesterone 21-hydroxylation. Conclusions These results suggest that CYP2D6 polymorphism can affect the stimulation/inhibition of progesterone 21-hydroxylation.
引用
收藏
页码:741 / 747
页数:7
相关论文
共 50 条
  • [21] Crystal structure of prinomastat bound human cytochrome P450 2D6
    Wang, An
    Savas, Uzen
    Stout, David C.
    Johnson, Eric F.
    FASEB JOURNAL, 2011, 25
  • [22] The Endocannabinoid Anandamide Is a Substrate for the Human Polymorphic Cytochrome P450 2D6
    Snider, Natasha T.
    Sikora, Matthew J.
    Sridar, Chitra
    Feuerstein, Thomas J.
    Rae, James M.
    Hollenberg, Paul F.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 327 (02): : 538 - 545
  • [23] Crystal Structure of Human Cytochrome P450 2D6 with Prinomastat Bound
    Wang, An
    Savas, Uzen
    Hsu, Mei-Hui
    Stout, C. David
    Johnson, Eric F.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (14) : 10834 - 10843
  • [24] Design and synthesis of fluorescent probes for human cytochrome P450 2D6
    Hanna, IH
    Cai, H
    Guengerich, FP
    FASEB JOURNAL, 1999, 13 (07): : A1347 - A1347
  • [25] The endocannabinoid anandamide is a substrate of cytochrome P450 2D6
    Snider, Natasha Tasheva
    Sridar, Chitra
    Hollenberg, Paul
    FASEB JOURNAL, 2008, 22
  • [26] Oxidation of methoxytyramines by recombinant cytochrome P450 2D6
    Hanna, IH
    Nishimura, Y
    Miller, GP
    Rizzo, CJ
    Guengerich, FP
    FASEB JOURNAL, 2000, 14 (08): : A1335 - A1335
  • [27] Hot flushes, tamoxifen and cytochrome P450 2D6
    Boutet, G.
    ONCOLOGIE, 2012, 14 (6-7) : 357 - 364
  • [28] Cytochrome P450 2D6 genetic polymorphisms of ugandans
    Miura, I.
    Saito, K.
    Obua, C.
    Abbo, C.
    Kaneko, S.
    Tateishi, T.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 103 - 103
  • [29] INHIBITION OF HUMAN CYTOCHROME P450 2D6 (CYP2D6) BY METHADONE
    WU, D
    OTTON, SV
    SPROULE, BA
    BUSTO, U
    INABA, T
    KALOW, W
    SELLERS, EM
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 35 (01) : 30 - 34
  • [30] The role of cytochrome P450 2D6 in the metabolism of moclobemide
    Hartter, S
    Dingemanse, J
    Baier, D
    Ziegler, G
    Hiemke, C
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1996, 6 (03) : 225 - 230